Locations
Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2022
Indu Pro is a biotechnology company focused on developing innovative drug therapies through proximity-based therapeutics. Their proprietary platforms, including Membrane Interactomics and ARRIS, enable the manipulation of protein interactions at the cell surface, creating new therapeutic opportunities for diseases such as cancer and autoimmune disorders. With a multidisciplinary team of experts from pharma and biotech, Indu Pro aims to redefine signaling pathways and enhance drug discovery processes. The company has raised significant funding to support its mission and is positioned to make a substantial impact in the field of protein therapeutics.
Something looks off?